News

Aquila moves into new areas of drug discovery


TRY IT NOW

Sign up online today & collaborate

or click here to find out more

Aquila moves into new areas of drug discovery

22/02/2016


Aquila Biomedical is now working in the area of immune oncology.

A BioQuarter spin-out facilitated by the Team, Aquila offers specialist drug discovery biological models. The company's original focus was in autoimmunity. But a recent move to focus on immune oncology has created the opportunity of discovering new therapies that can harness the capabilities of the immune system to remove cancer cells which had previously developed methods to evade the body's defence cells


 February edition of IQ for Sunergos Innovations

© Catalyst Innovation Portal 2019